ÂÜÀòÂÒÂ×

Ke Chen is currently the Vice President at STA Pharmaceutical, a WuXi AppTec Company, where they are responsible for late stage process development and manufacturing. Prior to this role, Ke served as an Executive Director at Bristol-Myers Squibb, leading a team to build robust processes for commercialization and develop control strategies for regulatory filings. With a postdoc in Organic Chemistry from Scripps Research, a PhD in Chemistry from the University of Rochester, and a Bachelor's degree from Peking University, Ke has a strong educational background to support their successful career in the pharmaceutical industry.